PARIS, July 11 (Reuters) - Sanofi Pasteur-MSD's cervical-cancer vaccine, Gardasil, will be 65 percent reimbursed in France for girls aged 14 to 23 years, the joint venture of drugmakers Sanofi-Aventis ...
Sanofi Pasteur MSD announced today that its quadrivalent HPV vaccine, Gardasil® has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use ...
MSD India is in dialogue with the government of India to include cervical cancer vaccine ‘Gardasil’ under the universal immunization programme (UIP). “We have approached the governments and ...
RAHWAY, N.J., March 17, 2026--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced it will present new clinical and real-world data reaffirming the ...
PARIS, Oct 4 (Reuters) - Sanofi Pasteur MSD said it aimed to extend the use of its cervical cancer vaccine treatment Gardasil, which competes with rival GlaxoSmithKline's Cervarix. "Sanofi Pasteur MSD ...
RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that new clinical and real-world data for the company’s 9-valent Human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results